the promise of pd1 inhibitors in kidney cancer
Published 10 years ago • 198 plays • Length 3:48Download video MP4
Download video MP3
Similar videos
-
16:48
kidney cancer immunotherapy: pd-1 pathway clinical trials
-
3:16
what is pd1 and pdl1 in kidney cancer?
-
2:22
are there pd1 biomarkers in kidney cancer?
-
1:21
the promise of immunotherapy in lung cancer
-
3:29
are there clinically significant distinctions between pd-1 and pd-l1?
-
2:27
do you order pd-l1 testing before choosing an immune checkpoint inhibitor?
-
2:35
the hottest thing in late stage kidney cancer
-
3:01
immune checkpoints and pd-l1 - lcvl 2024
-
18:46
kidney cancer immunotherapy: reasons for cautious optimism
-
9:52
kidney cancer immunotherapy q&a
-
23:37
gracecast-103_lung-cancer_immunotherapy: yervoy, anti-pd-1, reolysin, talactoferrin by dr. brahmer
-
5:06
should pd-l1 be used as a biomarker for immunotherapy in lung cancer?
-
7:41
gracecast-113_lung-cancer_asco 2012 lc highlights: dr. neal on anti-pd-1 immunotherapy for nsclc
-
11:16
immunotherapy for melanoma, pt. 2: immune checkpoints & the drugs that block them
-
6:42
adjuvant pembrolizumab: the ambassador trial - bladder cancer video library
-
3:46
immunotherapy as first-line treatment
-
13:18
the right time for cancer immunotherapy: before or after surgery?
-
14:46
immunotherapy for genitourinary cancers